Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Surgery|October 23, 2018
Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)Aaron T Scott, Patrick J Breheny, Kendall J Keck, et al.
Annals of Surgical Oncology|July 29, 2018
The Distal Predilection of Small Bowel Neuroendocrine TumorsKendall J Keck, Jessica E Maxwell, Alan F Utria, et al.
Surgery|December 12, 2024
GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptorsJonathan S Shilyansky, Casandro J Chan, Sophia Xiao, et al.
Surgery|November 21, 2017
Changes in gene expression in small bowel neuroendocrine tumors associated with progression to metastasesKendall J Keck, Patrick Breheny, Terry A Braun, et al.
Annals of Surgical Oncology|October 13, 2022
Surgical Management of G3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review and Meta-analysisIoannis A Ziogas, Panagiotis T Tasoudis, Luis C Borbon, et al.
Annals of Surgical Oncology|July 14, 2020
It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine TumorsCatherine G Tran, Scott K Sherman, Aaron T Scott, et al.
Annals of Surgical Oncology|July 8, 2022
Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?Luis C Borbon, Catherine G Tran, Scott K Sherman, et al.
The Biochemical Journal|October 3, 2002
Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat isletsBarbara A Cunningham, Ann-Marie T Richard, Joseph S Dillon, et al.
Annals of Surgical Oncology|April 24, 2019
The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine TumorsAaron T Scott, Daniel Pelletier, Jessica E Maxwell, et al.
Pageof 6